These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33406906)

  • 1. Effect of ovarian stimulation on embryo aneuploidy and mosaicism rate.
    Cascales A; Lledó B; Ortiz JA; Morales R; Ten J; Llácer J; Bernabeu R
    Syst Biol Reprod Med; 2021 Feb; 67(1):42-49. PubMed ID: 33406906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).
    Palmerola KL; Vitez SF; Amrane S; Fischer CP; Forman EJ
    J Assist Reprod Genet; 2019 Jan; 36(1):153-157. PubMed ID: 30362056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No effect of ovarian stimulation and oocyte yield on euploidy and live birth rates: an analysis of 12 298 trophectoderm biopsies.
    Irani M; Canon C; Robles A; Maddy B; Gunnala V; Qin X; Zhang C; Xu K; Rosenwaks Z
    Hum Reprod; 2020 May; 35(5):1082-1089. PubMed ID: 32348476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase gene polymorphisms are not associated with embryo chromosomal abnormalities and IVF outcomes.
    Morales R; Lledó B; Ortiz JA; Cascales A; Codina H; Rodríguez-Arnedo A; Llácer J; Bernabeu A; Bernabeu R
    Syst Biol Reprod Med; 2021 Aug; 67(4):270-280. PubMed ID: 34053384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preimplantation genetic testing is not a preferred recommendation for patients with X chromosome abnormalities.
    Li C; Dang Y; Li J; Li H; Zhu Y; Qin Y
    Hum Reprod; 2021 Aug; 36(9):2612-2621. PubMed ID: 34323971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of machine learning to predict aneuploidy and mosaicism in embryos from in vitro fertilization cycles.
    Ortiz JA; Morales R; Lledó B; Vicente JA; González J; García-Hernández EM; Cascales A; Ten J; Bernabeu A; Bernabeu R
    AJOG Glob Rep; 2022 Nov; 2(4):100103. PubMed ID: 36275401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of exogenous gonadotropin dosage on embryo aneuploidy rate and pregnancy outcome in patients of preimplantation genetic test].
    Zhang JN; Wang J; Peng HM; Ma MY; Wang H; Zhao CC; Jiao MY; Li XH; Yao YQ
    Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):253-258. PubMed ID: 32375432
    [No Abstract]   [Full Text] [Related]  

  • 8. Late follicular phase progesterone elevation during ovarian stimulation is not associated with decreased implantation of chromosomally screened embryos in thaw cycles.
    Hernandez-Nieto C; Lee JA; Alkon-Meadows T; Luna-Rojas M; Mukherjee T; Copperman AB; Sandler B
    Hum Reprod; 2020 Aug; 35(8):1889-1899. PubMed ID: 32649755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
    Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
    Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The true incidence of chromosomal mosaicism after preimplantation genetic testing is much lower than that indicated by trophectoderm biopsy.
    Wu L; Jin L; Chen W; Liu JM; Hu J; Yu Q; Ren XL; Huang B; He H
    Hum Reprod; 2021 May; 36(6):1691-1701. PubMed ID: 33860322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial.
    Baart EB; Martini E; Eijkemans MJ; Van Opstal D; Beckers NG; Verhoeff A; Macklon NS; Fauser BC
    Hum Reprod; 2007 Apr; 22(4):980-8. PubMed ID: 17204525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First PGT-A using human in vivo blastocysts recovered by uterine lavage: comparison with matched IVF embryo controls†.
    Munné S; Nakajima ST; Najmabadi S; Sauer MV; Angle MJ; Rivas JL; Mendieta LV; Macaso TM; Sawarkar S; Nadal A; Choudhary K; Nezhat C; Carson SA; Buster JE
    Hum Reprod; 2020 Jan; 35(1):70-80. PubMed ID: 31886877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Number of Euploid Embryos in Preimplantation Genetic Testing Cycles With Early-Follicular Phase Long-Acting Gonadotropin-Releasing Hormone Agonist Long Protocol.
    Li G; Wu Y; Niu W; Xu J; Hu L; Shi H; Sun Y
    Front Endocrinol (Lausanne); 2020; 11():424. PubMed ID: 32793112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should every embryo undergo preimplantation genetic testing for aneuploidy? A review of the modern approach to in vitro fertilization.
    Maxwell SM; Grifo JA
    Best Pract Res Clin Obstet Gynaecol; 2018 Nov; 53():38-47. PubMed ID: 30146380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polar body analysis by array comparative genomic hybridization accurately predicts aneuploidies of maternal meiotic origin in cleavage stage embryos of women of advanced maternal age.
    Christopikou D; Tsorva E; Economou K; Shelley P; Davies S; Mastrominas M; Handyside AH
    Hum Reprod; 2013 May; 28(5):1426-34. PubMed ID: 23477909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the IVF Cycle that Contribute to the Incidence of Mosaicism.
    Rodrigo L; Clemente-Císcar M; Campos-Galindo I; Peinado V; Simón C; Rubio C
    Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33007801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response.
    Sekhon L; Shaia K; Santistevan A; Cohn KH; Lee JA; Beim PY; Copperman AB
    J Assist Reprod Genet; 2017 Jun; 34(6):749-758. PubMed ID: 28321529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled ovarian hyperstimulation (COH) parameters associated with euploidy rates in donor oocytes.
    McCulloh DH; Alikani M; Norian J; Kolb B; Arbones JM; Munné S
    Eur J Med Genet; 2019 Aug; 62(8):103707. PubMed ID: 31252058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.